Janux Therapeutics Gains Amid Renewed Takeover Speculation

Seeking AlphaMay 3 04:09

Janux Therapeutics Jumps as Much as 28% on Heels of Deciphera Buyout Deal

Seeking AlphaApr 30 03:49

Janux a New Buy at Jones on Lead Assets for Solid Tumors

Seeking AlphaApr 17 02:25

A Glimpse Into The Expert Outlook On Janux Therapeutics Through 6 Analysts

In the latest quarter, 6 analysts provided ratings for Janux Therapeutics (NASDAQ:JANX), showcasing a mix of bullish and bearish perspectives.Summarizing their recent assessments, the table below illu

BenzingaApr 16 20:00

Janux Therapeutics (JANX.US) was first covered by JoneStrading, giving it a buy rating, with a target price of $70.00.

Janux Therapeutics (JANX.US) was first covered by JoneStrading, giving it a buy rating, with a target price of $70.00.

Zhitong FinanceApr 16 18:51

JonesTrading Initiates Coverage On Janux Therapeutics With Buy Rating, Announces Price Target of $70

JonesTrading analyst Soumit Roy initiates coverage on Janux Therapeutics with a Buy rating and announces Price Target of $70.

Analyst UpgradesApr 16 18:50